Suchergebnisse - "Kroeze, Stephanie G C"

PubPharm (83)

1

European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2024

von Scharl, S. | Zamboglou, C. | Strouthos, I. | +20

2

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Adebahr, S. | Althaus, A. | Scharl, S. | +24

3

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Adebahr, S. | Althaus, A. | Scharl, S. | +24

4

Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Scharl, S. | Zamboglou, C. | Strouthos, I. | +33

5

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Solomonidou, N. | Germanou, D. | Strouthos, I. | +25

6

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer

enthalten in: JAMA network open | 2023

von Zamboglou, C. | Peeken, J. | Janbain, A. | +27

7

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Solomonidou, N. | Germanou, D. | Strouthos, I. | +25

8

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

enthalten in: European journal of nuclear medicine & molecular imaging | 2023

von Solomonidou, N. | Germanou, D. | Strouthos, I. | +25

9

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Solomonidou, N. | Germanou, D. | Strouthos, I. | +25

10

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium

enthalten in: The Lancet. Oncology | 2023

von Kroeze, S. | Pavic, M. | Stellamans, K. | +31

1
2
3
4
5
6
7
8
9
Nächster »
[9]